Abstract:Background Group B Streptococcus (GBS), also referred as Streptococcus agalactiae , is one of the leading causes of life-threatening invasive diseases such as bacteremia, meningitis, pneumonia and urinary tract infection in pregnant women and neonates. Rates of GBS colonization vary by regions, but large-sample studies on maternal GBS status are limited in southern China. As a result, the prevalence of GBS among pregnant women and its associated risk factors and the efficacy of intrapartum antibiotic prophylaxis (IAP) intervention in preventing adverse pregnancy and neonatal outcomes remain poorly understood in southern China. Methods To fill this gap, we retrospectively analyzed demographic and obstetrical data of pregnant women who have undergone GBS screening and delivered between 2016 and 2018 in Xiamen, China. A total of 43,822 pregnant women were enrolled and only a few GBS-positive women did not receive IAP administration. Possible risk factors for GBS colonization were assayed by univariate and multivariate logistic regression analysis. Generalized linear regression model was applicated to analyze whether IAP is one of the impact factors of the hospital length of stay of the target women. Results The overall GBS colonization rate was 13.47% (5902/43,822). Although women > 35 years old ( P = 0.0363) and women with diabetes mellitus (DM, P = 0.001) had a higher prevalence of GBS colonization, the interaction between ages and GBS colonization was not statistically significant in Logistic Regression analysis (adjusted OR = 1.0014; 95% CI, 0.9950, 1.0077). The rate of multiple births was significantly dropped in GBS-positive group than that of GBS-negative group ( P = 0.0145), with no significant difference in the rate of fetal reduction ( P = 0.3304). Additionally, the modes of delivery and the incidences of abortion, premature delivery, premature rupture of membranes, abnormal amniotic fluid and puerperal infection were not significantly different between the two groups. The hospitalization stays of the subjects were not influenced by GBS infection. As for neonatal outcomes, the cases of fetal death in maternal GBS-positive group did not statistically differ from that in maternal GBS-negative group. Conclusion Our data identified that pregnant women with DM are at high risk of GBS infection and IAP is highly effective in prevention of adverse pregnancy and neonatal outcomes. This stressed the necessity of universal screening of maternal GBS status and IAP administration to the target population in China, and women with DM should be considered as priorities.

Group B Streptococcus and Intraamniotic Inflammation and Infection

[Rapid Group B Streptococcus Screening Methods in Late Pregnancy and the Maternal-Neonatal Outcomes].

Prevention of Perinatal Group B Streptococcus Infections

Association between Group B Streptococcus and Clinical Chorioamnionitis by Gestational Week at Delivery—A Multicenter Cohort Study

The Risk Factors for Group B Streptococcus Colonization During Pregnancy and Influences of Intrapartum Antibiotic Prophylaxis on Maternal and Neonatal Outcomes

Group B Streptococcus (GBS) Colonization and Disease among Pregnant Women: A Historical Cohort Study

Group B Streptococcus circumvents neutrophils and neutrophil extracellular traps during amniotic cavity invasion and preterm labor

Associated Risk Factors in Group B Streptococcus Infection During Pregnancy

Effects of group B streptococcus infection on vaginal micro-ecology and pregnancy outcomes of pregnant women in late pregnancy

Maternal GBS vaccination for preventing group B streptococcus disease in newborns: A mini review of current evidence

The current status of Group B Streptococcus infection in the reproductive tract of late-pregnancy women and its impact on pregnancy outcomes

Group B streptococcus colonization in pregnancy and neonatal outcomes: a three-year monocentric retrospective study during and after the COVID-19 pandemic

Maternal Group B Streptococcal Rectovaginal Colonization after Intrapartum Antibiotic Prophylaxis.

Risk of Early-Onset Neonatal Group B Streptococcal Disease With Maternal Colonization Worldwide: Systematic Review and Meta-analyses

[Detection of Maternal Colonization of Group B Streptococcus in Late Pregnancy by Real-Time Polymerase Chain Reaction and Its Effect on Perinatal Outcome].

Group B Streptococcus Induces Neutrophil Recruitment to Gestational Tissues and Elaboration of Extracellular Traps and Nutritional Immunity

Molecular-based screening for perinatal group B streptococcal infection: implications for prevention and therapy

[Analysis of screening strategy of group B streptococcus in the third trimester and its influence on pregnancy outcome]

Burden of infant group B Streptococcus disease and impact of maternal screening and antibiotic prophylaxis in Ontario, Canada: a population-based cohort study

Outcome of a screening programme for the prevention of neonatal invasive early-onset group B Streptococcus infection in a UK maternity unit: an observational study